An underground market for unlicensed slimming medications is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Drug Gaining Traction Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Commerce on Social Networks
Additionally, a robust market exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and claims of rapid British shipping. Sellers market the drug there before directing buyers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.
Some experts stated the demand for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the British medical regulations.
Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer laws, risking fines, prosecution or imprisonment.
Service Response and Content Removal
According to TikTok, the service has removed problematic material and banned associated keywords and query recommendations. The organization said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.
Online Trading Activities
Research also found groups with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately brings up channels with numerous of members, populated with photos of slimming results, positive reviews and step-by-step instructions for preparing or administering at home.
After moments of entering one group, a vendor shared contact information, where the majority of purchases take place. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.
Product Information and Pricing
Within these communities, messages show dark colored packages with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give contradictory responses varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for the messaging service stated it actively monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering materials they can’t verify. Even if the research behind this drug is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has already seen patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose users to possibly significant health risks”.
